60 related articles for article (PubMed ID: 20110001)
1. Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report.
Ali Hailan YM; Mudawi D; Yassin MA
Case Rep Oncol; 2021; 14(2):1004-1009. PubMed ID: 34326735
[TBL] [Abstract][Full Text] [Related]
2. Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients.
Dilli Batcha JS; Gota V; Matcha S; Raju AP; Rao M; Udupa KS; Mallayasamy S
Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38441626
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia presenting as compartment syndrome with acute loss of upper limb function.
D'Souza N; Somervaille TCP; Mowatt DJ
Am J Emerg Med; 2021 Nov; 49():273-275. PubMed ID: 34174777
[TBL] [Abstract][Full Text] [Related]
4. Incidentally Detected Kaposi Sarcoma of Adrenal Gland with Anaplastic Features in an HIV Negative Patient.
Celik ZE; Celik M; Sen E; Cebeci H; Ata O; Yavas C
Case Rep Pathol; 2016; 2016():1280201. PubMed ID: 27747121
[TBL] [Abstract][Full Text] [Related]
5. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.
Osorio S; Escudero-Vilaplana V; Reguilón-Gallego L; Gómez-Centurión I; Díez JL; Ferrer-Marín F
J Oncol Pharm Pract; 2017 Jan; ():1078155217735689. PubMed ID: 29065786
[TBL] [Abstract][Full Text] [Related]
6. Imatinib-induced pancreatitis.
Varma MR; Mathew S; Krishnadas D; Vinayakumar KR
Indian J Pharmacol; 2010 Feb; 42(1):50-2. PubMed ID: 20606838
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy.
D'Addona M; Pezzullo L; Giudice V; Serio B; Baldi C; Zeppa P; Selleri C
Clin Case Rep; 2022 Jun; 10(6):e05919. PubMed ID: 35677856
[TBL] [Abstract][Full Text] [Related]
8. A Case Report of Multiple Capillary Hemangioma in a Chronic Myeloid Leukemia Patient Taking Tyrosine Kinase Inhibitors.
Byun HJ; Jang D; Lee J; Oh SJ; Lim Y; Park JH; Lee JH; Lee DY
Ann Dermatol; 2021 Jun; 33(3):278-280. PubMed ID: 34079189
[TBL] [Abstract][Full Text] [Related]
9. High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors.
Martz J; Jain S; Vahdat LT; Qin L; Mosquera JM; Antonescu CR; Popa EC
J Clin Oncol; 2013 Apr; 31(11):e181-5. PubMed ID: 23439757
[No Abstract] [Full Text] [Related]
10. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
[TBL] [Abstract][Full Text] [Related]
11. Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML).
Walz C; Sattler M
Crit Rev Oncol Hematol; 2006 Feb; 57(2):145-64. PubMed ID: 16213151
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
[TBL] [Abstract][Full Text] [Related]
13. Hematological and molecular response evaluation of CML patients on imatinib.
Gupta A; Prasad K
J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
[TBL] [Abstract][Full Text] [Related]
14. Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia.
de Lemos JA; de Oliveira CM; Scerni AC; Bentes AQ; Beltrão AC; Bentes IR; Azevedo TC; Maradei-Pereira LM
Genet Mol Res; 2005 Dec; 4(4):803-11. PubMed ID: 16475128
[TBL] [Abstract][Full Text] [Related]
15. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
Usui N
Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
